The Effect of Interventional Therapy Combined With Interstitial Therapy on the Immune Function of Patients With Liver Cancer

Dazhi WANG,Xuya ZHAO,Wei HE,Shi ZHOU
DOI: https://doi.org/10.3969/j.issn.1674-9308.2015.25.071
2015-01-01
Abstract:Objective To explore the effect of the treatment of interventional therapy combined with interstitial therapy on the immune function of patients with liver cancer. Methods From January 2011 to January 2015, 196 cases of patients with advanced liver cancer were randomly divided into experimental group and control group, each of 98 cases. The control group was treated with transcatheter arterial chemoembolization (TACE), and the experimental group was treated with the combination of tumor interstitial therapy based on the control group. Immune function of the two groups were observed. Results After treatment, the CD3+ and CD4+ in the experimental group were significantly higher than those in the control group, the serum SIL and 2R were significantly lower than those in the control group, the difference was statistically significant, that is, P<0.05. The difference of CD8+ in the two groups was not statistically significant, that is, P>0.05. Conclusion Interventional therapy for treatment of liver cancer patients, not only can improve the immune function, but also promote the recovery of patients.
What problem does this paper attempt to address?